The 17th World Federation of Haemophilia International Musculoskeletal Congress in May brought together healthcare professionals from a range of disciplines to discuss musculoskeletal management approaches to haemophilia.
In this podcast, Dr Chee Wee Tan (Director of Haemophilia and Consultant Haematologist at the Royal Adelaide Hospital and Vice President of the Thrombosis and Haemostasis Society of Australia and New Zealand) and Ms Joanna McCosker (Paediatric Nurse Practitioner for Haemophilia at the Children’s Health Queensland Hospital and Health Service) discuss their highlights of the conference and implications of clinical practice here in Australia.
Sanofi Australia sponsored the production of this podcast but had no influence on the selection or commentary on the highlights from the conference.
Views and opinions expressed in this presentation are those of the presenters alone and does not necessarily reflect the views and opinions of Sanofi Australia. The information is not medical advice and no decision around the management of any patient should be made with reliance on the information contained in the podcast. It is your responsibility to prescribe appropriate treatment in accordance with your clinical judgement and the appropriate Australian production information.
sanofi-aventis australia pty ltd trading as Sanofi Genzyme | ABN: 31 008 558 807 | 12-24 Talavera Rd, Macquarie Park, NSW 2113 | 1800 818 806 Date of Preparation: October 2021 MAT-AU-2101803